Impact of bone marrow plasma cells percentage on survival at diagnosis and pre-transplant period in newly diagnosed multiple myeloma: Experience of a single center from Turkey

Ciftciler, Rafiye; GÖKER, HAKAN; BÜYÜKAŞIK, YAHYA; ALADAĞ KARAKULAK, ELİFCAN; Saglam, EMİNE; DEMİROĞLU, HALUK

doi:10.1016/j.transci.2019.03.017

Impact of bone marrow plasma cells percentage on survival at diagnosis and pre-transplant period in newly diagnosed multiple myeloma: Experience of a single center from Turkey

Atıf İçin Kopyala

Ciftciler R., GÖKER H., BÜYÜKAŞIK Y., ALADAĞ KARAKULAK E., Saglam E. A., DEMİROĞLU H.

TRANSFUSION AND APHERESIS SCIENCE, cilt.58, sa.3, ss.313-317, 2019 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 58 Sayı: 3
Basım Tarihi: 2019
Doi Numarası: 10.1016/j.transci.2019.03.017
Dergi Adı: TRANSFUSION AND APHERESIS SCIENCE
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.313-317
Hacettepe Üniversitesi Adresli: Evet

Özet

Background and aim: The current definition of complete remission (CR) in multiple myeloma (MM) includes negative serum and urine immunofixation (IFE) tests and < 5% bone marrow plasma cells (BMPCs). The aim of this study was to examine the impact of BMPC percentage on survival, at diagnosis and pre-transplant period, in newly diagnosed multiple myeloma.